Schematic overview of the cellular and molecular mechanisms involved in the cancer progression, including the proposed cellular and molecular mechanisms in cancer cells trajectory. AT1: alveolar type 1 cells; AT2: alveolar type 2 cells; AAH: atypical adenomatous hyperplasia; AIS: adenocarcinoma in situ; MIA: minimally invasive adenocarcinoma; IA: invasive adenocarcinoma; EMT: epithelial-mesenchymal transition

Home

Download

Statistics

Help

Contact

	Gene summary
	Malignant transformation analysis
	Malignant transformation related pathway analysis
	Cell-cell communication analysis
	Single-cell gene regulatory network inference analysis
	Somatic mutation of malignant transformation related genes
	Related drugs of malignant transformation related genes

Gene: SQSTM1

Gene summary for SQSTM1

Gene summary.

Gene information	Species	Human
	Gene symbol	SQSTM1
	Gene ID	8878
	Gene name	sequestosome 1
	Gene Alias	A170
	Cytomap	5q35.3
	Gene Type	protein-coding
	GO ID	GO:0000122
	UniProtAcc	Q13501

Top

Malignant transformation analysis

Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells

Malignant transformation involving gene list.

Entrez ID	Symbol	Replicates	Species	Organ	Tissue	Adj P-value	Log2FC	Malignancy
8878	SQSTM1	GSM5353222_PA_PB2B_Pool_1_3_S52_L002	Human	Prostate	Tumor	1.72e-02	-3.43e-01	0.1608
8878	SQSTM1	GSM5353223_PA_PB2B_Pool_2_S26_L001	Human	Prostate	Tumor	3.56e-02	-4.19e-01	0.1604
8878	SQSTM1	GSM5353227_PA_PR5199-193K_Pool_1_2_3_S55_L002	Human	Prostate	Tumor	8.92e-04	-4.15e-01	0.1602
8878	SQSTM1	GSM5353228_PA_PR5199-640K_Pool_1_3_S108_L004	Human	Prostate	Tumor	5.32e-03	-9.08e-01	0.1537
8878	SQSTM1	GSM5353243_PA_PR5261_T1_S23_L002	Human	Prostate	Tumor	3.09e-17	-3.50e-01	0.1545
8878	SQSTM1	GSM5353244_PA_PR5261_T2_S24_L002	Human	Prostate	Tumor	1.43e-07	-2.37e-01	0.1569
8878	SQSTM1	P1_S1_AK	Human	Skin	AK	7.52e-12	4.46e-01	-0.3399
8878	SQSTM1	P2_S3_AK	Human	Skin	AK	4.49e-05	3.85e-01	-0.3287
8878	SQSTM1	P2_S4_SCCIS	Human	Skin	SCCIS	3.71e-04	3.85e-01	-0.3043
8878	SQSTM1	P3_S6_AK	Human	Skin	AK	1.72e-02	2.63e-01	-0.3256
8878	SQSTM1	P4_S8_cSCC	Human	Skin	cSCC	1.20e-03	2.95e-01	-0.3095
8878	SQSTM1	P5_S10_cSCC	Human	Skin	cSCC	1.52e-56	8.22e-01	-0.299
8878	SQSTM1	P1_cSCC	Human	Skin	cSCC	1.98e-17	1.00e+00	0.0292
8878	SQSTM1	P4_cSCC	Human	Skin	cSCC	1.33e-07	5.49e-01	-0.00290000000000005
8878	SQSTM1	cSCC_p1	Human	Skin	cSCC	1.44e-06	-2.48e-01	-0.1916
8878	SQSTM1	cSCC_p11	Human	Skin	cSCC	2.21e-11	-4.25e-01	-0.2102
8878	SQSTM1	cSCC_p3	Human	Skin	cSCC	4.09e-18	-6.36e-01	-0.2085
8878	SQSTM1	cSCC_p4	Human	Skin	cSCC	4.27e-09	-4.93e-01	-0.2022
8878	SQSTM1	cSCC_p6	Human	Skin	cSCC	1.24e-15	-5.68e-01	-0.1989
8878	SQSTM1	cSCC_p7	Human	Skin	cSCC	1.30e-12	-5.69e-01	-0.2332

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Transcriptomic changes along malignancy continuum.

Tissue	Expression Dynamics	Abbreviation
Breast		IDC: Invasive ductal carcinoma
		DCIS: Ductal carcinoma in situ
		Precancer(BRCA1-mut): Precancerous lesion from BRCA1 mutation carriers
Cervix		CC: Cervix cancer
		HSIL_HPV: HPV-infected high-grade squamous intraepithelial lesions
		N_HPV: HPV-infected normal cervix
Endometrium		AEH: Atypical endometrial hyperplasia
		EEC: Endometrioid Cancer
Esophagus		ESCC: Esophageal squamous cell carcinoma
		HGIN: High-grade intraepithelial neoplasias
		LGIN: Low-grade intraepithelial neoplasias
GC		CAG: Chronic atrophic gastritis
		CAG with IM: Chronic atrophic gastritis with intestinal metaplasia
		CSG: Chronic superficial gastritis
		GC: Gastric cancer
		SIM: Severe intestinal metaplasia
		WIM: Wild intestinal metaplasia
Liver		HCC: Hepatocellular carcinoma
		NAFLD: Non-alcoholic fatty liver disease
Oral Cavity		EOLP: Erosive Oral lichen planus
		LP: leukoplakia
		NEOLP: Non-erosive oral lichen planus
		OSCC: Oral squamous cell carcinoma
Prostate		BPH: Benign Prostatic Hyperplasia
Skin		AK: Actinic keratosis
		cSCC: Cutaneous squamous cell carcinoma
		SCCIS:squamous cell carcinoma in situ
Thyroid		ATC: Anaplastic thyroid cancer
		HT: Hashimoto's thyroiditis
		PTC: Papillary thyroid cancer

∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.

Top

Malignant transformation related pathway analysis

Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer

Figure of enriched GO biological processes.

Tissue	Disease Stage	Enriched GO biological Processes
Colorectum	AD
Colorectum	SER
Colorectum	MSS
Colorectum	MSI-H
Colorectum	FAP

∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).

Page: 1 2 3 4 5 6 7 8 9

Enriched GO biological processes.

GO ID	Tissue	Disease Stage	Description	Gene Ratio	Bg Ratio	pvalue	p.adjust	Count
GO:19033209	Breast	Precancer	regulation of protein modification by small protein conjugation or removal	38/1080	242/18723	1.71e-08	1.17e-06	38
GO:19033219	Breast	Precancer	negative regulation of protein modification by small protein conjugation or removal	21/1080	95/18723	8.09e-08	4.61e-06	21
GO:00313969	Breast	Precancer	regulation of protein ubiquitination	33/1080	210/18723	1.45e-07	7.82e-06	33
GO:00313979	Breast	Precancer	negative regulation of protein ubiquitination	19/1080	83/18723	1.85e-07	9.54e-06	19
GO:0002931	Breast	Precancer	response to ischemia	12/1080	58/18723	9.65e-05	1.80e-03	12
GO:00004226	Breast	Precancer	autophagy of mitochondrion	14/1080	81/18723	2.01e-04	3.16e-03	14
GO:00617266	Breast	Precancer	mitochondrion disassembly	14/1080	81/18723	2.01e-04	3.16e-03	14
GO:00224119	Breast	Precancer	cellular component disassembly	44/1080	443/18723	3.17e-04	4.51e-03	44
GO:00108217	Breast	Precancer	regulation of mitochondrion organization	19/1080	144/18723	6.26e-04	7.78e-03	19
GO:19038299	Breast	Precancer	positive regulation of cellular protein localization	30/1080	276/18723	6.48e-04	7.99e-03	30
GO:19030085	Breast	Precancer	organelle disassembly	15/1080	114/18723	2.31e-03	2.15e-02	15
GO:19054777	Breast	Precancer	positive regulation of protein localization to membrane	14/1080	106/18723	3.07e-03	2.62e-02	14
GO:19043757	Breast	Precancer	regulation of protein localization to cell periphery	15/1080	125/18723	5.58e-03	4.07e-02	15
GO:19054757	Breast	Precancer	regulation of protein localization to membrane	19/1080	175/18723	5.98e-03	4.22e-02	19
GO:19043778	Breast	Precancer	positive regulation of protein localization to cell periphery	10/1080	69/18723	5.98e-03	4.22e-02	10
GO:00072496	Breast	Precancer	I-kappaB kinase/NF-kappaB signaling	27/1080	281/18723	6.58e-03	4.53e-02	27
GO:19030767	Breast	Precancer	regulation of protein localization to plasma membrane	13/1080	104/18723	6.79e-03	4.65e-02	13
GO:190332014	Breast	IDC	regulation of protein modification by small protein conjugation or removal	43/1434	242/18723	1.71e-07	9.16e-06	43
GO:003139614	Breast	IDC	regulation of protein ubiquitination	37/1434	210/18723	1.50e-06	6.36e-05	37
GO:190332114	Breast	IDC	negative regulation of protein modification by small protein conjugation or removal	22/1434	95/18723	2.16e-06	8.69e-05	22

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32

Enriched KEGG pathways.

Pathway ID	Tissue	Disease Stage	Description	Gene Ratio	Bg Ratio	pvalue	p.adjust	qvalue	Count
hsa0501416	Breast	Precancer	Amyotrophic lateral sclerosis	98/684	364/8465	2.13e-28	8.41e-27	6.44e-27	98
hsa0502216	Breast	Precancer	Pathways of neurodegeneration - multiple diseases	112/684	476/8465	6.96e-27	2.44e-25	1.87e-25	112
hsa0513118	Breast	Precancer	Shigellosis	44/684	247/8465	3.91e-07	6.86e-06	5.26e-06	44
hsa0541818	Breast	Precancer	Fluid shear stress and atherosclerosis	28/684	139/8465	4.74e-06	6.00e-05	4.59e-05	28
hsa042189	Breast	Precancer	Cellular senescence	29/684	156/8465	1.66e-05	1.69e-04	1.30e-04	29
hsa0501417	Breast	Precancer	Amyotrophic lateral sclerosis	98/684	364/8465	2.13e-28	8.41e-27	6.44e-27	98
hsa0502217	Breast	Precancer	Pathways of neurodegeneration - multiple diseases	112/684	476/8465	6.96e-27	2.44e-25	1.87e-25	112
hsa0513119	Breast	Precancer	Shigellosis	44/684	247/8465	3.91e-07	6.86e-06	5.26e-06	44
hsa0541819	Breast	Precancer	Fluid shear stress and atherosclerosis	28/684	139/8465	4.74e-06	6.00e-05	4.59e-05	28
hsa0421814	Breast	Precancer	Cellular senescence	29/684	156/8465	1.66e-05	1.69e-04	1.30e-04	29
hsa0501423	Breast	IDC	Amyotrophic lateral sclerosis	102/867	364/8465	1.29e-22	5.22e-21	3.91e-21	102
hsa0502223	Breast	IDC	Pathways of neurodegeneration - multiple diseases	116/867	476/8465	3.63e-20	1.18e-18	8.82e-19	116
hsa0541824	Breast	IDC	Fluid shear stress and atherosclerosis	34/867	139/8465	9.41e-07	1.61e-05	1.20e-05	34
hsa0421824	Breast	IDC	Cellular senescence	35/867	156/8465	5.49e-06	7.43e-05	5.56e-05	35
hsa0513124	Breast	IDC	Shigellosis	47/867	247/8465	1.78e-05	2.00e-04	1.49e-04	47
hsa0413723	Breast	IDC	Mitophagy - animal	17/867	72/8465	7.61e-04	6.04e-03	4.52e-03	17
hsa0501433	Breast	IDC	Amyotrophic lateral sclerosis	102/867	364/8465	1.29e-22	5.22e-21	3.91e-21	102
hsa0502233	Breast	IDC	Pathways of neurodegeneration - multiple diseases	116/867	476/8465	3.63e-20	1.18e-18	8.82e-19	116
hsa0541834	Breast	IDC	Fluid shear stress and atherosclerosis	34/867	139/8465	9.41e-07	1.61e-05	1.20e-05	34
hsa0421834	Breast	IDC	Cellular senescence	35/867	156/8465	5.49e-06	7.43e-05	5.56e-05	35

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Top

Cell-cell communication analysis

Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states

Ligand

Receptor

LRpair

Pathway

Tissue

Disease Stage

Page: 1

Top

Single-cell gene regulatory network inference analysis

Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states

Cell Type

Tissue

Disease Stage

Target Gene

RSS

Regulon Activity

∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.

Page: 1

Top

Somatic mutation of malignant transformation related genes

Annotation of somatic variants for genes involved in malignant transformation

Hugo Symbol

Variant Class

Variant Classification

dbSNP RS

HGVSc

HGVSp

HGVSp Short

SWISSPROT

BIOTYPE

SIFT

PolyPhen

Tumor Sample Barcode

Tissue

Histology

Sex

Age

Stage

Therapy Types

Drugs

Outcome

SQSTM1

SNV

Missense_Mutation

novel

c.1260N>T

p.Lys420Asn

p.K420N

Q13501

protein_coding

deleterious(0)

probably_damaging(0.999)

TCGA-AN-A046-01

Breast

breast invasive carcinoma

Female

>=65

I/II

Unknown

SQSTM1

SNV

Missense_Mutation

novel

c.465G>T

p.Glu155Asp

p.E155D

Q13501

protein_coding

deleterious(0.01)

probably_damaging(0.952)

TCGA-AN-A0AK-01

Breast

breast invasive carcinoma

Female

>=65

I/II

Unknown

SQSTM1

SNV

Missense_Mutation

c.494N>G

p.Lys165Arg

p.K165R

Q13501

protein_coding

tolerated(0.15)

benign(0.425)

TCGA-B6-A0IJ-01

Breast

breast invasive carcinoma

Female

<65

I/II

Unknown

SQSTM1

SNV

Missense_Mutation

rs772889843

c.1043N>T

p.Pro348Leu

p.P348L

Q13501

protein_coding

deleterious(0)

probably_damaging(0.981)

TCGA-BH-A0HA-01

Breast

breast invasive carcinoma

Female

<65

I/II

Unknown

SQSTM1

deletion

Frame_Shift_Del

novel

c.321_328delNNNNNNNN

p.Asp108ProfsTer42

p.D108Pfs*42

Q13501

protein_coding

TCGA-AN-A03X-01

Breast

breast invasive carcinoma

Female

>=65

I/II

Unknown

SQSTM1

insertion

Nonsense_Mutation

novel

c.1211_1212insTGAGCACTGAGTGAACCAGACTCCGTCTGCAATCCC

p.Met404delinsIleGluHisTerValAsnGlnThrProSerAlaIlePro

p.M404delinsIEH*VNQTPSAIP

Q13501

protein_coding

TCGA-AR-A0TY-01

Breast

breast invasive carcinoma

Female

<65

I/II

Unspecific

Paclitaxel

SQSTM1

SNV

Missense_Mutation

c.1099C>G

p.Leu367Val

p.L367V

Q13501

protein_coding

tolerated(0.11)

benign(0.007)

TCGA-FU-A5XV-01

Cervix

cervical & endocervical cancer

Female

<65

III/IV

Unknown

SQSTM1

SNV

Missense_Mutation

c.850T>G

p.Ser284Ala

p.S284A

Q13501

protein_coding

tolerated(0.42)

benign(0)

TCGA-AA-3492-01

Colorectum

colon adenocarcinoma

Female

>=65

I/II

Unknown

SQSTM1

SNV

Missense_Mutation

rs758625124

c.481N>T

p.Arg161Trp

p.R161W

Q13501

protein_coding

deleterious(0)

possibly_damaging(0.67)

TCGA-AA-3819-01

Colorectum

colon adenocarcinoma

Female

<65

I/II

Unknown

SQSTM1

SNV

Missense_Mutation

rs200551825

c.1178N>A

p.Arg393Gln

p.R393Q

Q13501

protein_coding

deleterious(0.01)

possibly_damaging(0.56)

TCGA-WS-AB45-01

Colorectum

colon adenocarcinoma

Female

<65

I/II

Unknown

Page: 1 2 3 4

Top

Related drugs of malignant transformation related genes

Identification of chemicals and drugs interact with genes involved in malignant transfromation

(DGIdb 4.0)

Entrez ID	Symbol	Category	Interaction Types	Drug Claim Name	Drug Name	PMIDs
8878	SQSTM1	SERINE THREONINE KINASE		IMX-942	DUSQUETIDE

Page: 1